Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

Journavx works differently than other available medications, and its developer, the biotechnology juggernaut Vertex Pharmaceuticals, has positioned it as an important, non-opioid option for pain ...

C) The location of volume of interest (VOI) for MRS (left ATL and vertex) and a representative MRS spectrum ... Coloured line represents the inverted U-shaped (quadratic) function between ATL GABA ...